Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: Enhancement with interleukin-2(IL-2), IL-12, and IL-15

Clinical Immunology and Immunopathology

Volumn 82, Issue 2, 1997, Pages 163-173

  Lin, Syh Jae ^a,c   Roberts, Robert L ^a   Ank, Bonnie J ^a   Nguyen, Quoc H ^a   Thomas, Elaine K ^b   Stiehm, E Richard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMGEN INC   (United States)

^c CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERIMMUNE GLOBULIN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; VIRUS ANTIGEN;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0031081145     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4298     Document Type: Article

References (39)

1. 1. Whiteside, T. L., and Herberman, R. B., Short analytic review. The role of natural killer cells in human disease. Clin. Immunol. Immunopathol. 53, 1-23, 1989.
2. 2. Ritz, J., Schmidt, R. E., Michon, J., Hercend, T., and Schlossman, S. F., Characterization of functional surface structure of human natural killer cells. Adv. Immunol. 42, 181-211, 1988.
3. 3. Siegel, F.P., Lopez, C., Fitzgerald, P.A., Shah, K., Baron, P., Leiderman, I. Z., Imperato, D., and Landesman, S., Opportunistic infections in acquired immunodeficiency syndrome resulting from synergistic defects of both the natural and adaptive component of cellular immunity. J. Clin. Invest. 78, 115-123, 1986.
4. 4. Bonagura, V. R., Cunningham-Rundles, S. L., and Schuval, S., Dysfunction of natural killer cells in HIV-infected children with or without Pneumocystis carinii pneumonia. J. Pediatr. 121, 195-201, 1992.
5. 5. Scott-Algara, D., Vuillier, F., Cayota, A., Rame, V., Guetard, D., Moncany, M. L. J., Marasescu, M., Dauguet, C., and Dighiero, G., In vitro non-productive infection of purified natural killer cells by the BRM isolate of the HIV isotype 1. J. Gen. Virol. 74, 725-731, 1993.
6. - cells with low lytic activity. J. Acquir. Immune. Defic. Syn. Hum. Retrovirol. 10, 331-340, 1995.
7. 7. Ahmad, A., and Menezes, J., Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 10, 258-266, 1996.
8. 8. Tyler, D. S., Stanley, S. D., Nastala, C. A., Austin, A. A., Bartlett, J. A., Stine, K. C., Lyerly, H. K., Bolognesi, D. P., and Weinhold, K. J., Alterations in antibody-dependent cellular cytotoxicity during the course of HIV infection: Humoral and cellular defects. J. Immunol. 144, 3375-3384, 1990.
9. + lymphocytes from HIV-seropositive homosexual men. Clin. Immunol. Immunopathol. 55, 297-304, 1990.
10. 10. Ahmad, A., Morisset, R., Thomas, R., and Menezes, J., Evidence for a defect of antibody-dependent cellular cytotoxicity (ADCC) effector function and anti-HIV gp120/41-specific ADCC mediating antibody titers in HIV-infected individuals. J. Acquir. Immune. Defic. Syn. Hum. Retrovirol. 7, 428-437, 1994.
11. 11. Brenner, B. G., Gryllis, C., Gornitsky, M., and Wainberg, M. A., Changes in natural immunity during the course of HIV-infection. Clin. Exp. Immunol. 93, 142-148, 1993.
12. 12. Ullum, H., Gotsche, P. C., Victor, J., Dickmeiss, E., Skinhoj, P., and Peterson, B. K., Defective natural immunity: An early manifestation of HIV infection. J. Exp. Med. 182, 789-799, 1995.
13. + effector cells armed in vivo with cytophilic antibody. J. Immunol. 142, 1177-1182, 1990.
14. 14. Weinhold, K.J., Lyerly, H. K., Matthews, T. J., Tyler, D.S., Ahearne, P. M., Stine, K. C., Langlois, A. J., Durack, D. T., and Bolognesi, D. P., Cellular anti-gp120 cytolytic reactivities in HIV-1 seropositive individuals. Lancet 1, 902-905, 1988.
15. 15. Murray, H. W., Welte, K., Jacob, J. L., Rubin, B. Y., Mertelsmann, R., and Roberts, R. B., Production and in vitro response to interleukin-2 in the acquired immunodeficiency syndrome. J. Clin. Invest. 76, 1959-1967, 1985.
16. 16. Chehimi, J., Starr, S. E., Frank, I., D'Andrea, A., Ma, X., MacGregor, R. R., Sennelier, J., and Trinchieri, G., Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179, 1361-1366, 1994.
17. 17. Kovacs, J. A., Baseler, M., Dewar, R. J., Vogel, S., Davey, R. T., Falloon, J., Polis, M. A., Walker, R. E., Stevens, R., Salzman, P. N., Metcalf, J. A., Masur, H., and Lane, H. C., Increase in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. New Engl. J. Med. 332, 567-575, 1995.
18. 18. Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Matthew, J. D., Hendrix, C. W., Wolf, S. F., and Shearer, G. M., Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262, 1721-1724, 1993.
19. 19. DeBlaker-Hohe, D. F., Yamauchi, A., Yu, C. R., Horvath-Arcidiacono, J. A., and Bloom, E. T., IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh NK cells. Cell. Immunol. 165, 33-43, 1995.
20. 20. Chehimi, J., Starr, S. E., Frank, I., Rengaraju, M., Jackson, S. J., Llanes, C., Kobayashi, M., Perussia, B., Young, D., Nickbarg, E., Wolf, S. F., and Trinchieri, G., Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175, 789-796, 1992.
21. 21. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., Johnson, L., Alderson, M. R., Watson, J. D., Anderson, D. M., and Giri, J. G., Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264, 965-968, 1994.
22. 22. Anderson, D. M., Kumaki, S., Ahdieh, M., Bertles, J., Tometsko, M., Loomis, A., Giri, J., Copeland, N. G., Gilbert, D. J., Jenkings, N. A., Valentine, V., Shapiro, D. N., Morris, S. W., Park, L. S., and Cosman, D., Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270, 29862-29869, 1995.
23. 23. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., and Caligiuri, M. A., Interleukin(IL)15 is a novel cytokine that activates human natural killer cells via components of IL-2 receptor. J. Exp. Med. 180, 1395-1403, 1994.
24. 24. Carson, W. E., Ross, M. E., Baiocchi, R. A., Marien, M. J., Boiani, N., Grabstein, K., and Caligiuri, M. A., Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96, 2578-2582, 1995.
25. 25. Szelc, C., Mitcheltree, C., Roberts, R. L., and Stiehm, E. R., Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. J. Infect. Dis. 166, 486-493, 1992.
26. 26. Stine, K. C., Bolognesi, D., and Weinhold, K. J., Cytokine augmentation of human immunodeficiency virus type-1 gp120-specific cellular cytotoxicity. J. Biol. Resp. Mod. 8, 501-510, 1988.
27. 27. Ye, J., Ortaldo, J. R., Conion, K., Winkler-Pickett, R., and Young, H. A., Cellular and molecular mechanisms of IFN-γ production induced by IL-2 and IL-12 in a human NK cell line. J. Leukocyte Biol. 58, 225-233, 1995.
28. 28. Herberman, R. B., Reynolds, C. W., and Ortaldo, J. R., Mechanism of cytotoxicity by natural killer (NK) cells. Annu. Rev. Immunol. 4, 651-680, 1986.
29. 29. Arase, H., Arase, N., and Saito, T., Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181, 1235-1238, 1995.
30. 30. Eischen, C. M., Schilling, J. D., Lynch, D. H., Krammer, P. H., and Leibson, P. J., Fc Receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 156, 2693-2699, 1996.
31. 31. Oyaizu, N., Mcclosekey, T. W., Than, S., Hu, R., Kalyanaraman, V. S., and Pahwa, S., Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood 84, 2622-2631, 1994.
32. + natural killer cell subset during HIV infection. Cytometry 22, 10-15, 1995.
33. 33. Tyler, D. S., Lyerly, H. K., and Weinhold, K. J., Minireview. Anti-HIV ADCC. AIDS Res. Hum. Retroviruses 5, 557-563, 1989.
34. 34. Wang, X. P., Oyaizu, N., and Pahwa, S., Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide specific antibodies in infants with vertical HIV infection. Pediatr. Res. 38, 384-389, 1995.
35. 35. Baum, L. L., Cassutt, K. J., Knigge, K, Khattri, R., Margolick, J., Rinaldo, C., Kleeberger, C. A., Nishanian, P., Henrard, D. R., and Phair, J., HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J. Immunol. 157, 2168-2173, 1996.
36. 36. Patki, A. H., Quinones-Mateu, M. E., Dorazio, D., Yen-Lieberman, B., Boom, W. H., Thomas, E. K., and Lederman, M. M., Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. J. Clin. Invest. 98, 616-621, 1996.
37. 37. Jacobson, E. L., Pilaro, F., and Smith, K. A., Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity. Proc. Natl. Acad. Sci. USA 93, 10405-10410, 1996.
38. 38. Munger, W., DeJoy, S. Q., Jeyaseelan SR, R., Torley, L. W., Grabstein, K. H., Eisenmann, J., Poxton, R., Cox, T., Wick, M. M., and Kerwar, S. S., Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: Comparison with interleukin-2. Cell. Immunol. 165, 289-293, 1995.
39. 39. Volberding, P., Moody, D. J., Beardslee, D., Breadley, E. C., and Wofsy, C. B., Therapy of the acquired immunodeficiency syndrome with recombinant interleukin-2. AIDS Res. Hum. Retroviruses 3, 115-124, 1987.